View in EDS HTML Full Text PDF Full Text

Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL.

Saved in:
Bibliographic Details
Title: Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL.
Authors: Strati, Paolo1 (AUTHOR), Ahmed, Mohamed Amin1 (AUTHOR), Nastoupil, Loretta J.1 (AUTHOR), Feng, Lei2 (AUTHOR), Hagemeister, Fredrick B.1 (AUTHOR), Fayad, Luis E.1 (AUTHOR), Rodriguez, Maria A.1 (AUTHOR), Samaniego, Felipe1 (AUTHOR), Wang, Michael1 (AUTHOR), Westin, Jason R.1 (AUTHOR), Lee, Hun J.1 (AUTHOR), Iyer, Swaminathan P.1 (AUTHOR), Parmar, Simrit1 (AUTHOR), Ahmed, Sairah1 (AUTHOR), Nair, Ranjit1 (AUTHOR), Steiner, Raphael E.1 (AUTHOR), Noorani, Mansoor1 (AUTHOR), Flowers, Christopher R.1 (AUTHOR), Davis, R. Eric1 (AUTHOR), Fowler, Nathan H.1 (AUTHOR)
Source: Leukemia & Lymphoma. Jun2020, Vol. 61 Issue 6, p1380-1387. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2020.1716221